NortonLifeLock Inc. (NASDAQ:NLOK) Shares Sold by Morgan Stanley

Share on StockTwits

Morgan Stanley trimmed its position in NortonLifeLock Inc. (NASDAQ:NLOK) by 45.8% during the 1st quarter, HoldingsChannel.com reports. The firm owned 1,094,428 shares of the company’s stock after selling 923,259 shares during the period. Morgan Stanley’s holdings in NortonLifeLock were worth $20,476,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of NLOK. Capital World Investors acquired a new stake in shares of NortonLifeLock during the 4th quarter worth approximately $1,668,264,000. BlackRock Inc. lifted its holdings in NortonLifeLock by 8.1% in the first quarter. BlackRock Inc. now owns 45,170,494 shares of the company’s stock valued at $845,139,000 after acquiring an additional 3,372,482 shares during the last quarter. Franklin Resources Inc. purchased a new position in NortonLifeLock in the fourth quarter worth approximately $762,700,000. Geode Capital Management LLC increased its stake in NortonLifeLock by 10.9% during the first quarter. Geode Capital Management LLC now owns 10,206,835 shares of the company’s stock worth $190,634,000 after acquiring an additional 1,007,051 shares during the last quarter. Finally, Beutel Goodman & Co Ltd. purchased a new stake in NortonLifeLock in the fourth quarter valued at $252,629,000. Institutional investors own 88.19% of the company’s stock.

In other news, President Samir Kapuria sold 45,162 shares of the firm’s stock in a transaction on Wednesday, May 20th. The shares were sold at an average price of $20.61, for a total value of $930,788.82. Following the sale, the president now directly owns 291,481 shares in the company, valued at approximately $6,007,423.41. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Peter A. Feld sold 10,900,195 shares of NortonLifeLock stock in a transaction on Monday, June 8th. The stock was sold at an average price of $20.97, for a total transaction of $228,577,089.15. Following the sale, the director now directly owns 40,008 shares of the company’s stock, valued at $838,967.76. The disclosure for this sale can be found here. 0.40% of the stock is currently owned by corporate insiders.

Shares of NASDAQ NLOK opened at $19.43 on Wednesday. The stock has a market cap of $11.26 billion, a P/E ratio of 3.23, a PEG ratio of 3.59 and a beta of 0.91. The business’s fifty day simple moving average is $20.51 and its 200-day simple moving average is $21.62. NortonLifeLock Inc. has a 12-month low of $15.12 and a 12-month high of $28.70. The company has a current ratio of 1.17, a quick ratio of 1.17 and a debt-to-equity ratio of 353.80.

NortonLifeLock (NASDAQ:NLOK) last issued its quarterly earnings results on Thursday, May 14th. The company reported $0.26 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.19 by $0.07. The company had revenue of $610.00 million for the quarter, compared to the consensus estimate of $602.21 million. NortonLifeLock had a return on equity of 11.63% and a net margin of 125.92%. During the same quarter in the prior year, the business earned $0.16 EPS. On average, equities analysts forecast that NortonLifeLock Inc. will post 0.89 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which was paid on Wednesday, June 24th. Investors of record on Wednesday, June 10th were paid a dividend of $0.125 per share. The ex-dividend date of this dividend was Tuesday, June 9th. This represents a $0.50 dividend on an annualized basis and a dividend yield of 2.57%. NortonLifeLock’s payout ratio is 66.67%.

NLOK has been the subject of a number of research analyst reports. Stifel Nicolaus increased their price target on NortonLifeLock from $19.00 to $21.00 and gave the stock a “hold” rating in a report on Friday, May 15th. Citigroup increased their target price on shares of NortonLifeLock from $19.00 to $21.00 and gave the stock a “neutral” rating in a research note on Friday, May 15th. Credit Suisse Group lifted their price target on shares of NortonLifeLock from $17.00 to $19.00 and gave the company a “neutral” rating in a research report on Friday, May 15th. Zacks Investment Research lowered shares of NortonLifeLock from a “buy” rating to a “hold” rating and set a $20.00 price objective on the stock. in a report on Tuesday, April 14th. Finally, Mizuho increased their price objective on shares of NortonLifeLock from $21.00 to $23.00 and gave the stock a “buy” rating in a research report on Friday, May 15th. They noted that the move was a valuation call. Seven equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. The stock currently has an average rating of “Hold” and a consensus target price of $22.64.

NortonLifeLock Company Profile

NortonLifeLock Inc provides cyber security products, services, and solutions worldwide. The company offers Norton security solutions as a subscription service providing protection for devices against malware, viruses, adware, and ransomware on various platforms; and LifeLock identity theft protection solution that provides identity monitoring, alerts, and restoration to its customers.

Recommended Story: Why Dividend Stocks May Be Right for You

Want to see what other hedge funds are holding NLOK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for NortonLifeLock Inc. (NASDAQ:NLOK).

Institutional Ownership by Quarter for NortonLifeLock (NASDAQ:NLOK)

Receive News & Ratings for NortonLifeLock Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NortonLifeLock and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Tower Research Capital LLC TRC Purchases New Shares in FedEx Co.
Tower Research Capital LLC TRC Purchases New Shares in FedEx Co.
Squarepoint Ops LLC Reduces Stock Position in Verrica Pharmaceuticals Inc
Squarepoint Ops LLC Reduces Stock Position in Verrica Pharmaceuticals Inc
Squarepoint Ops LLC Increases Position in Veritex Holdings Inc
Squarepoint Ops LLC Increases Position in Veritex Holdings Inc
Invesco Ltd. Raises Stock Position in Nextgen Healthcare Inc
Invesco Ltd. Raises Stock Position in Nextgen Healthcare Inc
APG Asset Management N.V. Takes $275,000 Position in IBERIABANK Corp
APG Asset Management N.V. Takes $275,000 Position in IBERIABANK Corp
Alliancebernstein L.P. Acquires 6,531 Shares of Colony Capital Inc
Alliancebernstein L.P. Acquires 6,531 Shares of Colony Capital Inc


 
© 2006-2020 Zolmax.